Overview

Spectrum Pharmaceuticals is a biopharmaceutical company focused on acquiring, developing, and commercializing novel and targeted oncology therapies. The company aims to bring innovative treatments to patients with cancer to improve patient outcomes.

Therapeutic areas

Active pharmaceutical ingredients supplied

Substances Spectrum Pharmaceuticals is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

Spectrum Pharmaceuticals holds 0 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • APAZIQUONEInactive2015-11-30

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Spectrum Pharmaceuticals in our records. PharmaTek screens the full directory against live FDA enforcement data.

Verified Supplier Partner

Is this Spectrum Pharmaceuticals? Get in front of buyers actively sourcing.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.